Amendment to Securities Purchase Agreement between Generex Biotechnology Corporation and Purchasers (April 13, 2011)

Summary

Generex Biotechnology Corporation and the purchasers under a Securities Purchase Agreement dated January 24, 2011 have agreed to extend the deadline for the purchasers' option to buy additional shares and warrants. The new deadline for exercising this option is June 3, 2011, allowing the purchasers to acquire up to $3,000,000 in additional securities at the agreed price. This amendment is confirmed by Generex's Interim President and CEO.

EX-10.1 2 v218664_ex10-1.htm Unassociated Document

April 13, 2011

Dear Sirs:

Re:

Generex Biotechnology Corporation

Securities Purchase Agreement dated January 24, 2011

We make reference to the Securities Purchase Agreement (the “Agreement”) dated January 24, 2011 between Generex Biotechnology Corporation (the “Company”) and each of the addressees (severally) to this letter (collectively, the “Purchasers”).

The Company hereby acknowledges and agrees that the definition of the term “Subsequent Closing Option Date” in the Agreement is hereby amended by extending such date from April 25, 2011 (as per the Company’s letter to the Purchasers of March 25, 2011) to June 3, 2011. Accordingly, the Purchasers’ option to purchase an additional aggregate $3,000,000 of Shares and Warrants at the Per Share Purchase Price (as those capitalized terms are defined in the Agreement) is exercisable through June 3, 2011.

Yours truly,

Generex Biotechnology Corporation

/s/ Mark A. Fletcher

Mark A. Fletcher,

Interim President & Chief Executive Officer

maf/hs